Methysergide derivatives
AssigneeMAP Pharmaceuticals, Inc.
InventorsLibo Wu, Jian Zhang
Life of this patent
Estimating the term…
Abstract
Provided herein are novel methysergide derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders or symptoms thereof, such as, migraine and Parkinson's disease using the compounds and compositions disclosed herein. In still other embodiments, provided herein, such as, for example, are methods for antagonizing the 5-HT2B receptor without agonizing the 5-HT2B receptor using the compounds and compositions disclosed herein. In still other embodiments, provided herein such as, for example, are methods of agonizing the 5-HT1A receptor using the compounds and compositions disclosed herein.
Claims3
The compound having the structure:
- or salts thereof.
The compound having the structure:
- or salts thereof.
The compound having the structure:
- or salts thereof.
Dependencies are inferred from the claim text.